These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 32927646)

  • 1. Interleukin-15 after Near-Infrared Photoimmunotherapy (NIR-PIT) Enhances T Cell Response against Syngeneic Mouse Tumors.
    Maruoka Y; Furusawa A; Okada R; Inagaki F; Wakiyama H; Kato T; Nagaya T; Choyke PL; Kobayashi H
    Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32927646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined CD44- and CD25-Targeted Near-Infrared Photoimmunotherapy Selectively Kills Cancer and Regulatory T Cells in Syngeneic Mouse Cancer Models.
    Maruoka Y; Furusawa A; Okada R; Inagaki F; Fujimura D; Wakiyama H; Kato T; Nagaya T; Choyke PL; Kobayashi H
    Cancer Immunol Res; 2020 Mar; 8(3):345-355. PubMed ID: 31953245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Near-Infrared Photoimmunotherapy Combined with CTLA4 Checkpoint Blockade in Syngeneic Mouse Cancer Models.
    Maruoka Y; Furusawa A; Okada R; Inagaki F; Fujimura D; Wakiyama H; Kato T; Nagaya T; Choyke PL; Kobayashi H
    Vaccines (Basel); 2020 Sep; 8(3):. PubMed ID: 32937841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Near-Infrared Photoimmunotherapy of Cancer.
    Kobayashi H; Choyke PL
    Acc Chem Res; 2019 Aug; 52(8):2332-2339. PubMed ID: 31335117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumoral IL15 Improves Efficacy of Near-Infrared Photoimmunotherapy.
    Fukushima H; Furusawa A; Kato T; Wakiyama H; Takao S; Okuyama S; Choyke PL; Kobayashi H
    Mol Cancer Ther; 2023 Oct; 22(10):1215-1227. PubMed ID: 37461129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased Immunogenicity of a Minimally Immunogenic Tumor after Cancer-Targeting Near Infrared Photoimmunotherapy.
    Wakiyama H; Furusawa A; Okada R; Inagaki F; Kato T; Maruoka Y; Choyke PL; Kobayashi H
    Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33322807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Near Infrared Photoimmunotherapy for Cancer].
    Kobayashi H
    Gan To Kagaku Ryoho; 2019 Jan; 46(1):28-33. PubMed ID: 30765637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Near infrared photoimmunotherapy of cancer; possible clinical applications.
    Wakiyama H; Kato T; Furusawa A; Choyke PL; Kobayashi H
    Nanophotonics; 2021 Sep; 10(12):3135-3151. PubMed ID: 36405499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syngeneic Mouse Models of Oral Cancer Are Effectively Targeted by Anti-CD44-Based NIR-PIT.
    Nagaya T; Nakamura Y; Okuyama S; Ogata F; Maruoka Y; Choyke PL; Allen C; Kobayashi H
    Mol Cancer Res; 2017 Dec; 15(12):1667-1677. PubMed ID: 28923838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host Immunity Following Near-Infrared Photoimmunotherapy Is Enhanced with PD-1 Checkpoint Blockade to Eradicate Established Antigenic Tumors.
    Nagaya T; Friedman J; Maruoka Y; Ogata F; Okuyama S; Clavijo PE; Choyke PL; Allen C; Kobayashi H
    Cancer Immunol Res; 2019 Mar; 7(3):401-413. PubMed ID: 30683733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opening up new VISTAs: V-domain immunoglobulin suppressor of T cell activation (VISTA) targeted near-infrared photoimmunotherapy (NIR-PIT) for enhancing host immunity against cancers.
    Wakiyama H; Furusawa A; Okada R; Inagaki F; Kato T; Furumoto H; Fukushima H; Okuyama S; Choyke PL; Kobayashi H
    Cancer Immunol Immunother; 2022 Dec; 71(12):2869-2879. PubMed ID: 35445836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Near infrared photoimmunotherapy of B-cell lymphoma.
    Nagaya T; Nakamura Y; Sato K; Harada T; Choyke PL; Kobayashi H
    Mol Oncol; 2016 Nov; 10(9):1404-1414. PubMed ID: 27511870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneously Combined Cancer Cell- and CTLA4-Targeted NIR-PIT Causes a Synergistic Treatment Effect in Syngeneic Mouse Models.
    Kato T; Okada R; Furusawa A; Inagaki F; Wakiyama H; Furumoto H; Okuyama S; Fukushima H; Choyke PL; Kobayashi H
    Mol Cancer Ther; 2021 Nov; 20(11):2262-2273. PubMed ID: 34518299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of Antibody Fragments on CD25 Targeted Regulatory T Cell Near-Infrared Photoimmunotherapy.
    Okada R; Maruoka Y; Furusawa A; Inagaki F; Nagaya T; Fujimura D; Choyke PL; Kobayashi H
    Bioconjug Chem; 2019 Oct; 30(10):2624-2633. PubMed ID: 31498995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local Depletion of Immune Checkpoint Ligand CTLA4 Expressing Cells in Tumor Beds Enhances Antitumor Host Immunity.
    Okada R; Kato T; Furusawa A; Inagaki F; Wakiyama H; Choyke PL; Kobayashi H
    Adv Ther (Weinh); 2021 May; 4(5):. PubMed ID: 33997271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective depletion of polymorphonuclear myeloid derived suppressor cells in tumor beds with near infrared photoimmunotherapy enhances host immune response.
    Kato T; Fukushima H; Furusawa A; Okada R; Wakiyama H; Furumoto H; Okuyama S; Takao S; Choyke PL; Kobayashi H
    Oncoimmunology; 2022; 11(1):2152248. PubMed ID: 36465486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Near-infrared photoimmunotherapy targeting human-EGFR in a mouse tumor model simulating current and future clinical trials.
    Okada R; Furusawa A; Vermeer DW; Inagaki F; Wakiyama H; Kato T; Nagaya T; Choyke PL; Spanos WC; Allen CT; Kobayashi H
    EBioMedicine; 2021 May; 67():103345. PubMed ID: 33933782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Near-infrared photoimmunotherapy of cancer: a new approach that kills cancer cells and enhances anti-cancer host immunity.
    Kobayashi H; Furusawa A; Rosenberg A; Choyke PL
    Int Immunol; 2021 Jan; 33(1):7-15. PubMed ID: 32496557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the Effectiveness of IgG Antibody versus F(ab')
    Kato T; Okada R; Furusawa A; Wakiyama H; Furumoto H; Fukushima H; Okuyama S; Choyke PL; Kobayashi H
    Mol Pharm; 2022 Oct; 19(10):3600-3611. PubMed ID: 35759343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Near-infrared photoimmunotherapy of pancreatic cancer using an indocyanine green-labeled anti-tissue factor antibody.
    Aung W; Tsuji AB; Sugyo A; Takashima H; Yasunaga M; Matsumura Y; Higashi T
    World J Gastroenterol; 2018 Dec; 24(48):5491-5504. PubMed ID: 30622378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.